A SAFETY, TOLERABILITY AND PHARMACOKINETICS (PK) STUDY OF SINGLE AND MULTIPLE DOSES OF LECOZOTAN SUSTAINED RELEASE (SR), A NOVEL 5-HT1A ANTAGONIST, IN HEALTHY YOUNG SUBJECTS: 95


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles